Ringing Ear Relief (The Magni Company)


Welcome to the PulseAid listing for the Ringing Ear Relief drug offered from The Magni Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: The Magni Company
NON-PROPRIETARY NAME: Calcarea Carbonica, Chininum Sulphuricum, Kali Carbonicum, Lycopodium Clavatum, Salicylicum Acidum
SUBSTANCE NAME: OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUININE SULFATE; POTASSIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; SALICYLIC ACID
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-07-28
END MARKETING DATE: 2021-02-03


Ringing Ear Relief HUMAN OTC DRUG Details:

Item DescriptionRinging Ear Relief from The Magni Company
LABELER NAME: The Magni Company
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 6; 6; 6; 6([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2015-07-28
END MARKETING DATE: 2021-02-03
PRODUCT ID: 43689-0014_09207789-b929-4e7d-a9e6-573b9e4ee350
PRODUCT NDC: 43689-0014
APPLICATION NUMBER:

Other OYSTER SHELL CALCIUM CARBONATE, CRUDE; QUININE SULFATE; POTASSIUM CARBONATE; LYCOPODIUM CLAVATUM SPORE; SALICYLIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
The Magni CompanyTinnitus Relief